← FDA Drug Approvals (Drugs@FDA)

BRIMONIDINE TARTRATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MICRO LABS · Approved 2023-11-22

Drug application

FDA Application #

ANDA217846

Application type

Abbreviated New Drug Application (Generic)

Brand name

BRIMONIDINE TARTRATE

Generic name

BRIMONIDINE TARTRATE

Active ingredients

BRIMONIDINE TARTRATE

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

Marketing status

Prescription

Sponsor

MICRO LABS

Manufacturer

Micro Labs Limited

First approval

2023-11-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown